Vane
Impact in
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 17
- Inflammatory mediators and NSAID effects 17
- Biochemistry 13
- Eicosanoids and Hypertension Pharmacology 12
- Co-authors
- Salvador Moncada (19 shared papers)Ferreira Sh (4 shared papers)Herman Ag (6 shared papers)S Bunting (1 shared paper)R J Flower (3 shared papers)Piper Pj (2 shared papers)S. Moncada (2 shared papers)Marc J. Claeys (1 shared paper)
- Journals
- Journal of Endocrinology (1 paper)PubMed (47 papers)Europe PMC (PubMed Central) (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Vane
50 papers receiving 979 citations
Peers
Comparison fields: 5 of 96
- Biochemistry 275
- Pharmacology 510
- Cardiology and Cardiovascular Medicine 236
- Internal Medicine 30
- Pharmacology 79
Countries citing papers authored by Vane
This map shows the geographic impact of Vane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vane more than expected).
Fields of papers citing papers by Vane
This network shows the impact of papers produced by Vane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vane. The network helps show where Vane may publish in the future.
Co-authors
The 14 scholars most cited alongside Vane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The role of prostacyclin in vascular tissue. | 1979 | 266 |
| 2 | Prostaglandins as mediators of inflammation. | 1976 | 166 |
| 3 | The effects of antiinflammatory drugs on the production of prostaglandins in vivo. | 1976 | 62 |
| 4 | Inhibitors of prostaglandin, prostacyclin, and thromboxane synthesis. | 1978 | 60 |
| 5 | Bioassay of prostaglandins and biologically active substances derived from arachidonic acid. | 1978 | 46 |
| 6 | Prostacyclin in physiology and pathophysiology. | 1982 | 44 |
| 7 | Further experiments to establish that the analgesic action of aspirin-like drugs depends on the inhibition of prostaglandin biosynthesis. | 1973 | 41 |
| 8 | Prostacyclin release induced by bradykinin may contribute to the antihypertensive action of angiotensin-converting enzyme inhibitors. | 1980 | 39 |
| 9 | Appearance of prostaglandins in the renal venous blood of dogs in response to acute systemic hypotension produced by bleeding or endotoxin. | 1973 | 38 |
| 10 | Prostaglandins and the regulation of blood pressure. | 1975 | 31 |
| 11 | Prostacyclin and its clinical applications. | 1984 | 26 |
| 12 | Prostacyclin: a hormone with a therapeutic potential. The Sir Henry Dale Lecture for 1981. | 1982 | 23 |
| 13 | Prostacyclin is produced in whole blood [proceedings]. | 1978 | 21 |
| 14 | Regulatory mechanisms of the vascular endothelium: an update. | 1995 | 20 |
| 15 | Some cardiovascular properties of prostacyclin (PGI2) which are not shared by PGE2. | 1980 | 19 |
| 16 | Relative potency of prostacyclin, prostaglandin E1 and D2 as inhibitors of platelet aggregation in several species [proceedings]. | 1977 | 17 |
| 17 | Formation of prostacyclin and its product 6-oxo-PGF1alpha by the gastric mucosa of several species [proceedings]. | 1978 | 16 |
| 18 | Endothelins: potent releasers of prostacyclin and EDRF. | 1991 | 15 |
| 19 | Prostacyclin as a potent dilator of arterioles in the hamster cheek pouch [proceedings]. | 1978 | 15 |
| 20 | Endotoxin and production of prostaglandins by the isolated rabbit jejunum. Influence of indomethacin. | 1975 | 13 |
About Vane
Vane is a scholar working on Pharmacology, Biochemistry, Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology, having authored 51 papers that have together received 1.2k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (17 papers), Eicosanoids and Hypertension Pharmacology (12 papers), HIV/AIDS drug development and treatment (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Synthesis of β-Lactam Compounds (3 papers), Diet and metabolism studies (2 papers), Nitric Oxide and Endothelin Effects (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Biochemistry (275 citations), Pharmacology (510 citations), Cardiology and Cardiovascular Medicine (236 citations), Internal Medicine (30 citations) and Pharmacology (79 citations). Vane has collaborated with scholars based in United Kingdom. Frequent co-authors include Salvador Moncada, Ferreira Sh, Herman Ag, S Bunting, R J Flower, Piper Pj, S. Moncada, Marc J. Claeys, Robin D. Hughes and Vanhoutte Pm. Their work appears in journals such as Journal of Endocrinology, PubMed and Europe PMC (PubMed Central).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.